Categories: Health

Cipla Health reinforces importance of Self-Care This Season Through Its Range of Wellness Products

With a rise in COVID cases and seasonal flu, Cipla Health’s trusted portfolio empowers everyday health decisions for Indian families

- Advertisement -

MUMBAI, India, July 1, 2025 /PRNewswire/ — Common flu, seasonal throat infections, and fevers are on the rise in India, making it imperative to practice every day self-care and community protection. Leading the charge, Cipla Health Ltd., one of India’s most trusted fast-moving wellness goods (FMWG) companies, through its thoughtful and medically backed range of products, offers holistic support to navigate the ongoing seasonal challenges that have also seen a resurgence in respiratory illnesses like COVID-19.

- Advertisement -

Cipla Health’s house of brands, including Cofsils, Cipladine, Prolyte ORS, Paracip, and Maxirich offers reliable solutions for Indian households to better manage these symptoms and maintain wellness.

- Advertisement -
  • Cofsils Lozenges offer fast relief from sore throat pain—starting in just 5 minutes. With a triple-action formula that fights viruses, bacteria and soothing effects, they’re a handy companion when you’re out and about.
  • Cipladine Gargles target throat infections right at the source. With povidone-iodine, a trusted ingredient for throat hygiene, it soothes symptoms like sore throat and tonsillitis and helps reduce the spread of viruses. It’s also effective for on-demand oral care during seasonal illness.
  • Prolyte ORS is the go-to rehydration solution when one is feeling drained from fever or illness. Its WHO-recommended formula helps restore lost fluids and electrolytes, so they can bounce back quicker and stay balanced.
  • Paracip is Cipla Health’s reliable paracetamol that helps ease common seasonal discomforts like body aches, headaches, and chills
  • Maxirich Daily Multivitamin helps keeping the energy up and immunity strong. Packed with over 13 essential vitamins and minerals, it supports everyone’s daily health needs.

Commenting on this, Mr. Shivam Puri, MD & CEO, Cipla Health Limited, said, “At Cipla Health, our focus is to bring dependable preventive wellness solutions to every Indian household. With the weather shifting and instances of seasonal flu, respiratory illnesses on the rise, it is imperative to have access to simple yet effective care solutions. Our product portfolio has been thoughtfully designed to support families in staying prepared and protected.”

- Advertisement -

By offering solutions rooted in science, Cipla Health continues to fulfil its mission of making wellness accessible, proactive, and holistic for all. Whether it’s the common seasonal flu or an unseen viral wave, being prepared with the right care tools can go a long way in staying safe.

- Advertisement -

About Cipla Health Limited:

- Advertisement -

Cipla Health Limited, the fast-moving wellness goods (FMWG) arm of Cipla, was incorporated in 2015 with a vision to spearhead the wellness wave in India. Cipla Health has delivered rapid growth and today plays across a diverse portfolio of 20 brands with most key brands being No. 1 or No. 2 in their respective categories. The portfolio includes products in Pain Care (Omnigel), Smoking Cessation (Nicotex), Oral Rehydration Solutions (Prolyte), Medicated Ointments (Cipladine), Cough & Cold (Cofsils and Naselin), Multi Vitamins (Maxirich), Weight Gain (Endura Mass) and Personal Care (Rivela Dermascience, Cetafresh, Tugain Essentials).

- Advertisement -

Logo: https://mma.prnewswire.com/media/2658055/5252537/Cipla_Health_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/cipla-health-reinforces-importance-of-self-care-this-season-through-its-range-of-wellness-products-302495467.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

6 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago